 Home > Active Ingredient News > Immunology News > A&R: Prevalence of Site-Specific Osteoarthritis 1990-2019: Findings from the Global Burden of Disease Study 2019

A&R: Prevalence of Site-Specific Osteoarthritis 1990-2019: Findings from the Global Burden of Disease Study 2019

 Last Update: 2022-08-16
 Source: Internet
 Author: User

Tags

site list

measure specific gravity

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Objectives : To estimate system- and anatomically-specific age-standardized prevalence rates (ASR) of osteoarthritis (OA) and to analyze long-term trends in OA at global, regional, and national level.

Objectives To estimate systemic and anatomical site-specific age-standardized prevalence rates (ASR) of osteoarthritis (OA) and to analyze long-term trends in OA at global, regional, and national level.

Methods : Data were obtained from the 2019 Global Burden of Disease Stu.

Methods Data were obtained from the 2019 Global Burden of Disease Stu.

As a result , globally, the prevalence of OA increased by 1125% , from 2451 million in 1990 to 5281 million in 201

Conclusions: OA has been a major public health concern worldwide over the past few decade.

Source: Long,.
, Liu,.
, Yin,.
, Wang,.
, Diao,.
, Zhang,.
, Lin,.
and Guo,.
(2022), Prevalence Trends of Site- Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 201 Arthritis Rheumatol, 74: 1172-118 https://d.
org/11002/a.
42089 Leave a comment here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Top Quality 99.9% Ritlecitinib Tosylate Immunoregulation API & Inflammation Inhibitor

CAS No.: 2192215-81-7

Pharmacy Grade; Food Grade

$200-250/G FOB

β-Alanine107-95-9

CAS No.: 107-95-9

$1-1.1/KG FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.